Prophylactic donor lymphocyte infusions after first allogeneic hematopoietic stem cell transplantation in children with acute leukemia
Prophylactic DLI transfusion following allogeneic HSCT remains a safe and effective treatment for pediatric patients with AL and can reduce post-transplant relapse and improve long-term survival.
Authors
- Lixiao Cai
- Ang Wei (ORCID: https://orcid.org/0000-0002-7046-2417)
- Maoquan Qin (ORCID: https://orcid.org/0000-0003-2704-8592)
- Chenguang Jia (ORCID: https://orcid.org/0000-0003-2514-1048)
- Yanhui Luo (ORCID: https://orcid.org/0000-0001-8714-5883)
- Yuanfang Jing
- Wei Chen (ORCID: https://orcid.org/0000-0003-3461-6658)
- H. J. Yang (ORCID: https://orcid.org/0009-0004-8274-9863)
- Meng Zhang (ORCID: https://orcid.org/0000-0003-1852-0322)
- Bin Wang (ORCID: https://orcid.org/0009-0007-2557-0754)
- Chang Shu (ORCID: https://orcid.org/0000-0001-5619-0294)
- Ximu Sun
- Ying Han (ORCID: https://orcid.org/0000-0001-8583-4060)
- Guanghua Zhu
- Jie Zheng (ORCID: https://orcid.org/0000-0002-7612-7206)
Institutions
- Capital Medical University (CN)
- Capital Institute of Pediatrics (CN)
- National Center for Women and Children’s Health, China CDC (CN)
- Ministry of Education (KR)
- Beijing Children’s Hospital (CN)
- Baoding University (CN)
- Baoding People's Hospital (CN)
Publication Details
- Journal
- Blood Research
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1007/s44313-025-00111-4
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00